Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Training Course (Dec 10, 2025)

Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Training Course is organized by International Professional and Industry (IPI) Academy, Management Forum (Mf) Ltd and will be held on Dec 10, 2025.

Description:
Antimicrobial resistance (AMR) has emerged as a daunting global challenge, threatening to undermine decades of medical advancements. It occurs when microorganisms such as bacteria, viruses, fungi, and parasites no longer respond to antimicrobial drugs, rendering treatments ineffective. This phenomenon jeopardises our ability to treat infections, leading to longer illnesses, increased mortality, and soaring healthcare costs. AMR's impact extends beyond human health; it affects veterinary medicine, agriculture, and the environment, creating a complex, interconnected ‘One Health’ crisis.

This comprehensive course delves into the intricacies of antimicrobial resistance (AMR) through the lens of the ‘One Health’ framework. Participants will gain insight into the regulatory landscapes governing AMR, understand the multifaceted challenges posed by AMR across different sectors, and explore innovative solutions, including alternatives to antibiotics like microbiome-derived antimicrobials and policy approaches. The course is designed to foster a holistic understanding of how human, animal, and environmental health are interconnected in the fight against AMR.

Benefits of Attending:

• Gain a thorough understanding of AMR and the ‘One Health’ approach, including regulatory mechanisms and future trends
• Learn about current and emerging regulations related to AMR at national and international levels
• Explore real-world examples of current research and development in alternative treatments and AMR management and discover innovative solutions for tackling this global issue, including cutting-edge research on microbiome-derived antimicrobials, phages and phytogenics
• Participate in Q&A sessions, interactive discussions and case studies, connecting with professionals across various sectors
• Collaborate on developing imaginative solutions and novel approaches to tackle AMR